It is challenging to navigate biosimilars regulation and the payer landscape, provide real world evidence to physicians, and compete for the right sites and patients. IQVIA can help you overcome these obstacles and make better decisions throughout your study's lifecycle using a customized approach backed by expertise in more than 15 therapeutic areas.
It starts when you leverage the power of the IQVIA Connected Intelligence™. This is how we use unparalleled data, transformative technology, advanced analytics, and scientific expertise to help achieve study goals and bring biosimilar drugs to market faster.
Customizable scope of solutions to meet your study needs
The trajectory of biosimilars has changed – and according to current projections, will continue on an upward path. With continued increases in biologics spending expected, the biosimilars market presents an opportunity for savings on medicines.
Achieving Sustainable Levels of Biosimilar Competition in Europe
Competition, Savings, and Sustainability
Focus oncology development on the patient, manage trial complexity, and increase predictability and speed.
Understand the science in treating diabetes with broadening populations, expanding treatment options, and new digital support tools.
Strengthen your portfolio by making more informed decisions and prepare for the impact of new research discoveries.
.svg){kind=icon}
